Sign Up

6548 Forest Park Pkwy, St. Louis, MO 63112, USA

#WashUBME

Presenting on “Axolotl Biosciences: Spinning off a biotechnology company from an academic research lab”

Stephanie Willerth, PhD, Professor, Canada Research Chair in biomedical engineering, acting director of centre for biomedical research, and acting director of undergraduate biomedical engineering program at the University of Victoria, will speak at 4:00 p.m. on Thursday, February 24, 2022 in Brauer 012. If you plan to attend virtually, registration is required

Abstract:
This talk will discuss Dr. Willerth’s experiences in taking her lab’s novel bioink technology from her lab to market. Dr. Willerth spun off her award winning biotechnology company -  Axolotl Biosciences from her research laboratory in March 2020. Axolotl Biosciences envisions advancing the fields of tissue engineering and regenerative medicine by developing and providing innovative products for 3D bioprinting. Our short-term strategy focuses on production and distribution of our novel bioinks as reagents for use by academic researchers while generating revenue starting this year. Strong demand for our bioinks exists from academic researchers due to their superior performance compared to commercially available bioinks, giving us a competitive advantage. We currently have our initial product – TissuePrint available for commercial purchase. Dr. Willerth will discuss how to license your technology as well as how to obtain non-dilutive funding for funding company operations.

NOTE: Parking is available outside of Whitaker Hall in the East End Garage. Click here for the map. If taking the subway, the nearest metrolink stop is Skinker.

0 people are interested in this event


If you plan to attend virtually, registration is required

6548 Forest Park Pkwy, St. Louis, MO 63112, USA

#WashUBME

Presenting on “Axolotl Biosciences: Spinning off a biotechnology company from an academic research lab”

Stephanie Willerth, PhD, Professor, Canada Research Chair in biomedical engineering, acting director of centre for biomedical research, and acting director of undergraduate biomedical engineering program at the University of Victoria, will speak at 4:00 p.m. on Thursday, February 24, 2022 in Brauer 012. If you plan to attend virtually, registration is required

Abstract:
This talk will discuss Dr. Willerth’s experiences in taking her lab’s novel bioink technology from her lab to market. Dr. Willerth spun off her award winning biotechnology company -  Axolotl Biosciences from her research laboratory in March 2020. Axolotl Biosciences envisions advancing the fields of tissue engineering and regenerative medicine by developing and providing innovative products for 3D bioprinting. Our short-term strategy focuses on production and distribution of our novel bioinks as reagents for use by academic researchers while generating revenue starting this year. Strong demand for our bioinks exists from academic researchers due to their superior performance compared to commercially available bioinks, giving us a competitive advantage. We currently have our initial product – TissuePrint available for commercial purchase. Dr. Willerth will discuss how to license your technology as well as how to obtain non-dilutive funding for funding company operations.

NOTE: Parking is available outside of Whitaker Hall in the East End Garage. Click here for the map. If taking the subway, the nearest metrolink stop is Skinker.